Zoetis-Neogen genomics business deal raises antitrust concerns in New Zealand
MLex Summary: Global animal health company Zoetis’ proposed acquisition of Neogen Corporation is raising antitrust concerns for New Zealand’s competition regulator. In a statement on Thursday, the New Zealand Commerce Commission,...To view the full article, register now.
Already a subscriber? Click here to view full article